Abbott India has recently recalled its Digene Gel product from the market after the Drug Controller General of India (DCGI) issued an advisory against its sale. Drug Controller General of India (DCGI) ...

Drug manufacturer Abbott India has recalled all batches of the antacid syrup, Digene gel, which were manufactured at its Goa facility. The medicine, which is pink in colour, was recalled after ...

HYDERABAD, India (Reuters) - India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged ...

Healthcare major Abbott said its Baddi plant (Himachal Pradesh) would supply additional stocks of the antacid Digene Gel, following a recent recall of the product made at its Goa plant. Abbott had ...

The Drugs Control General of India (DCGI) has issued an advisory alert against Abbott’s antacid Digene gel. The regulator has asked patients to discontinue the use of Digene Gel manufactured at the ...

HYDERABAD, India, Sept 14 (Reuters) - India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged ...

New Delhi: Drugmaker Abbott India has voluntarily recalled several batches of antacid Digene Gel, following which the Drug Controller General of India (DCGI) issued an advisory against using the ...

HYDERABAD, India, Sept 14 (Reuters) - India's Goa state has warned the local unit of Abbott Laboratories ABT.N it plans to suspend the manufacturing license of its popular antacid medicine after ...

Abbott says there is no impact on patient health. The Goa plant is one of Abbott's two factories in India, where Digene has a 7 per cent share of the market for so-called antiflatulent medicines, ...